4 Growth Stocks, 4 Value Stocks to Buy Now

For your continued consideration, 8 more stock recommendations from the latest issue of U.S. News Invested, four for growth, four for value.  Enjoy the weekend.  

JULY 15, 2022 Invested Advice, rankings and stock market news for investors.

Good morning, investors. Markets end down, and JPMorgan's CEO issues a dire warning. Highlights of today's newsletter include our market insights plus these new articles: 4 Growth Stocks, 4 Value Stocks to Buy Now 7 High-Risk Stocks For Aggressive Investors What We Can Learn From Past U.S. Recessions TODAY'S FEATURED STOCK STORY 4 Growth Stocks, 4 Value Stocks to Buy Now It's hard to make sense of all the headlines that are assailing investors in 2022. Is the negativity overdone, with the impacts of inflation and rising rates already baked into stocks? Or is this just the beginning phases of a long-term downturn that requires investors to get defensive? If you're in the first camp, you may be looking for growth-oriented stocks poised to break out if and when things recover. If you're in the second, then you may want solid value-oriented plays that offer a nice dividend as a hedge against additional declines. Whatever your perspective, the following list has something to offer via four top value stocks and four top growth stocks to consider right now: Growth stock - Lantheus Holdings Inc. (ticker: LNTH). If you haven't yet heard about Lantheus holdings, then you may be surprised to learn that this health care stock has doubled in 2022 even as the rest of Wall Street has been in a tailspin. That includes a stunning 40% surge over just a day or two in February thanks to spectacular earnings. Specifically, in the fourth quarter of 2021 Lantheus saw revenue surge almost 40% and profits explode four times higher over the prior year. Growth that spectacular may not be sustainable in the long term for this diagnostics company, but with projections that FY2022 sales will double over the prior year and then settle into double-digit expansion in the years ahead, there's clearly a lot of reasons to be optimistic about this midsized health play. Value stock - Nutrien Ltd. (NTR). The roughly $50 billion Nutrien is about as rock solid a company as you'll find on Wall Street. It's one of the largest dedicated agricultural companies on the planet, wholly focused on agricultural products and financial solutions for the farmers that needs these materials. NTR not only serves an essential part of the global economy by supporting food production, it dominates its niche and has the scale that makes it hard for others to compete. Small wonder that in this risk-off environment, NTR stock has held flat through the year even as other stocks have struggled in 2022. And while perhaps not the most attractive dividend payer among the value investments on this list, the 3.3% yield is above the roughly 1.6% paid by S&P 500 companies on average. Click here to continue reading.